The treatment of Bladder Infection & Eye Health with vitamins

Bladder Infection and Eye Health: Mitamins custom make quality formulas for the treatment of Bladder Infection & Eye Health with vitamins. A Bladder Infection & Eye Health formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Bladder Infection and Eye Health

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    500
    mg
    833%
    Vitamin E
    100
    IU
    333%
    Zinc
    10
    mg
    67%
    Lutein
    1000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Bioflavonoid Concentrate
    100
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    Goldenseal Extract
    250
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Bladder Infection and Eye Health
Serving Size:4-5

Bladder Infection and Eye Health Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Falling Platelet Counts May Signal HIV-Linked Dementia (HealthDay)
HIV-infected patients with declining blood platelet counts may be at increased risk for HIV-associated dementia, which causes a number of cognitive, behavioral and motor skill problems, researchers report.
Lupus Foundation Of America Statement On Results For Clinical Study Of CellCept(R) Released By Aspreva Pharmaceutical Company
The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinical trials for CellCept(R), a potential treatment for lupus kidney disease being tested by Aspreva Pharmaceutical Company.
This information concerning the support of Bladder Infection and Eye Health treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments